deltatrials
Completed NA INTERVENTIONAL 3-arm NCT03654209

Post-resection Treatment of Large Colon Polyps (SAP)

Prospective Randomized Controlled Trial Describing the Recurrence Rate of Adenomas in Sessile or Flat Colonic Lesions 15mm or Larger Receiving Post-resection Site Treatment With Snare Tip Soft Coagulation or Argon Plasma Coagulation

Sponsor: Erbe USA Incorporated

Conditions Recurrence
Updated 17 times since 2018 Last updated: Jan 2, 2024 Started: Oct 16, 2018 Primary completion: Dec 14, 2022 Completion: Dec 14, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03654209, this NA trial focuses on Recurrence and remains completed. Sponsored by Erbe USA Incorporated, it has been updated 17 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2018 – ~Nov 2018 · 2 months · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Sep 2019 · 9 months · monthly snapshot~Sep 2019 – ~Jan 2020 · 4 months · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Sep 2020 · 7 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Nov 2021 · 9 months · monthly snapshot~Nov 2021 – ~Sep 2022 · 10 months · monthly snapshot~Sep 2022 – ~Mar 2023 · 6 months · monthly snapshot~Mar 2023 – ~Jun 2023 · 3 months · monthly snapshot~Jun 2023 – ~Feb 2024 · 8 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

17 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Feb 2024 — Jul 2024 [monthly]

    Completed NA

  5. Jun 2023 — Feb 2024 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

Show 12 earlier versions
  1. Mar 2023 — Jun 2023 [monthly]

    Active Not Recruiting NA

  2. Sep 2022 — Mar 2023 [monthly]

    Active Not Recruiting NA

  3. Nov 2021 — Sep 2022 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  4. Feb 2021 — Nov 2021 [monthly]

    Recruiting NA

  5. Jan 2021 — Feb 2021 [monthly]

    Recruiting NA

  6. Sep 2020 — Jan 2021 [monthly]

    Recruiting NA

  7. Feb 2020 — Sep 2020 [monthly]

    Recruiting NA

  8. Jan 2020 — Feb 2020 [monthly]

    Recruiting NA

  9. Sep 2019 — Jan 2020 [monthly]

    Recruiting NA

  10. Dec 2018 — Sep 2019 [monthly]

    Recruiting NA

  11. Nov 2018 — Dec 2018 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  12. Sep 2018 — Nov 2018 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Erbe USA Incorporated
  • Indiana University
Data source: Indiana University

For direct contact, visit the study record on ClinicalTrials.gov .